In 2004, Wu et al. discovered that a high level of EphA2 protein expression in cervical cancer could decrease overall survival, suggesting that EphA2 may be a valuable clinical marker for cervical cancer [11]. The gene discussed is EPHA2; the disease is cervical carcinoma.